Lauren Panco

Partnership will enhance physician awareness of START’s portfolio of trials, streamline referrals, and support patient access to early-phase oncology research The START Center for Cancer Research (“START”), the world’s largest community-based network of clinical trial sites specializing in early-phase oncology trials, today announced a strategic partnership with Trialing, a platform dedicated to connecting physicians and

Dr. Smith will strengthen XenoSTART’s position as a premier drug development partner, translating PDX-driven insights into faster, more confident oncology development decisions. The START Center for Cancer Research (“START”), today announced the appointment of Frank Smith, PhD, MBA, as President of XenoSTART, its preclinical business unit. In this role, Dr. Smith will oversee XenoSTART’s operations,

Dr. Hafez will lead the new early-phase research site at Los Angeles Cancer Network, one of the nation’s largest and most diverse community-based oncology practices The START Center for Cancer Research (“START”), the world’s largest community-based network specializing in early-phase oncology trials, today announced the appointment of Navid Hafez, MD, MPH, as Director of Clinical

The first START site in New York launches new strategic partnership to provide cutting-edge cancer research Northwell Health and The START Center for Cancer Research held a ceremonial ribbon-cutting to unveil Northwell-START New York-Long Island, which reflects a $5.7 million investment for a 10,000-square foot, state-of-the-art early-phase cancer clinical trial center. Located at Northwell’s outpatient